rct
2011
High Quality
Selenium and the Course of Mild Graves' Orbitopathy
Marcocci C, Kahaly GJ, Krassas GE, Bartalena L, Wiersinga WM
Published in New England Journal of Medicine
Key Findings
Sodium selenite 200 mcg/day for 6 months improved quality of life, reduced eye involvement and slowed progression of mild Graves' orbitopathy versus placebo.
Conclusions
Selenium supplementation benefits patients with mild Graves' orbitopathy in a marginally selenium-deficient population.
Supplements Studied
Selenium
Mineral
Selenium administration significantly improved quality of life, reduced ocular involvement, and slowed progression of the disease in patients with mild Graves' orbitopathy.
Related Health Concerns
Study Details
Year:2011
Sample Size:159
Quality Score:9/10
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.